KAZIA THERAPEUTICS-SPON ADR (KZIA) Stock Analyst Ratings

NASDAQ:KZIA • US48669G3039

6.135 USD
-0.12 (-2%)
At close: Feb 20, 2026
5.77 USD
-0.37 (-5.95%)
After Hours: 2/13/2026, 8:21:13 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to KZIA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 19.38. This target is 215.89% above the current price.
  • KZIA was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about KZIA.
  • In the previous month the buy percentage consensus was at a similar level.
  • KZIA was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
KZIA Historical Analyst RatingsKZIA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Price Target & Forecast

Price Low Median Mean High 6.1418.1819.3819.3821.00 - 196.33% 215.89% 215.89% 242.30%

Related screens

Find peers 30% below price target
KZIA Current Analyst RatingKZIA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2026-01-28 HC Wainwright & Co. Reiterate Buy -> Buy
2025-12-12 HC Wainwright & Co. Maintains Buy -> Buy
2025-10-02 Maxim Group Maintains Buy -> Buy
2025-07-10 HC Wainwright & Co. Maintains Buy -> Buy
2025-06-11 Maxim Group Maintains Buy -> Buy
2025-02-06 Maxim Group Initiate Buy
2024-07-12 HC Wainwright & Co. Reiterate Buy -> Buy
2023-04-11 HC Wainwright & Co. Upgrade Neutral -> Buy
2022-08-02 Maxim Group Downgrade Buy -> Hold
2022-08-02 HC Wainwright & Co. Downgrade Buy -> Neutral
2021-10-14 Maxim Group Initiate Buy

KAZIA THERAPEUTICS-SPON ADR / KZIA FAQ

Can you provide the average price target for KAZIA THERAPEUTICS-SPON ADR stock?

8 analysts have analysed KZIA and the average price target is 19.38 USD. This implies a price increase of 215.89% is expected in the next year compared to the current price of 6.135.


Can you provide the consensus rating for KAZIA THERAPEUTICS-SPON ADR stock?

The consensus rating for KAZIA THERAPEUTICS-SPON ADR (KZIA) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.


What is the number of analysts for KZIA stock?

The number of analysts covering KAZIA THERAPEUTICS-SPON ADR (KZIA) is 8.